MDT vs PEN
MDT: Global medical device leader deploying pacemakers, defibrillators, spinal implants, surgical robotics, and diabetes management systems to alleviate pain, restore health, and extend life across 150+ countries. PEN: The world's leading mechanical thrombectomy company enabling rapid, minimally invasive blood clot removal across ischemic stroke, pulmonary embolism, and limb ischemia.
Side-by-side fundamentals
| Metric | MDT | PEN | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $81.89 | $316.50 | |
| Market cap as of 2026-07-23 | $105.1B | $12.4B | |
| P/E as of 2026-07-23 | 21.88 | 72.79 | MDT lower |
| PEG as of 2026-07-23 | 2.90 | 0.24 | PEN lower |
| Net margin as of 2026-07-23 | +13.2% | +11.8% | MDT higher |
| Gross margin as of 2026-07-23 | +65.3% | +67.4% | PEN higher |
| Operating margin as of 2026-07-23 | +17.8% | +12.9% | MDT higher |
| ROE as of 2026-07-23 | +9.8% | +12.3% | PEN higher |
| ROA as of 2026-07-23 | +5.2% | +9.6% | PEN higher |
| Debt / equity as of 2026-07-23 | 0.57 | 0.02 | PEN lower |
| Revenue growth (YoY) as of 2026-07-23 | +8.4% | +17.3% | PEN higher |
| Revenue CAGR (3y) SEC XBRL | +5.2% | +18.3% | PEN higher |
| Dividend yield as of 2026-07-23 | +3.5% | n/a | |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-07-23 | 0.57 | 0.70 | |
| 1-year return as of 2026-07-22 close | -10.6% | +36.5% | PEN higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.